And what else would the Pacific Edge diagnostic test utilising midkine as a biomarker (in combination with others) be other than something getting clinical validity and in COMMERCIAL USE.
Admittedly its only one of several alleged cancers but its definitely the first that has gone this far.
I suspect the others will follow eventually depending on the application.
Everyone seems to forget all about this groundbreaking test.
What is taking the time is changing clinical procedures which is a mighty big ball of wax.
Anna Nordin: Midkine in Advanced Prostate Cancer, page-11
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable